It was a pleasure to speak with Anja Tuulonen (Tays Eye Centre, Tampere University Hospital, Tampere, Finland), who talked us through her presentation on the ‘big four’ eye diseases, and the real-life cost-effectiveness of interventions to treat them.
- What proportion of eye diseases are accounted for by the ‘big four’? (00:20)
- What are the major challenges of resource allocation within ophthalmology? (00:52)
- Why is it so important to measure real-life effectiveness of interventions in ophthalmology? (01:59)
- Could you give us a brief overview of the model developed in Finland to optimize the effectiveness, sustainability and outcomes of eyecare services? (03:19)
- What are the strengths of the model and how do you hope this approach will be adopted? (04:59)
Speaker Disclosure: Anja Tuulonen has no financial or non-financial relationships or activities to declare in relation to this interview.
Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Lisa Glass.
Filmed in coverage of ESCRS 2021.
